Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2; Delivery Systems

Treatments: Drug: insulin aspart

Study type: Observational

Funder types: Industry

Identifiers

NCT00675220

ANA-1884

Details and patient eligibility

About

This study is conducted in Asia. The aim of this observational study is to collect efficacy and safety data in diabetic patients with acute hyperglycemia using NovoRapid™ FlexPen™ as per normal clinical practice.

Enrollment: 373 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with diabetes mellitus (according to product labelling)

Exclusion criteria

• Hypoglycaemia
• Hypersensitivity to insulin aspart or to any of the excipients (according to product labelling)

Trial design

373 participants in 1 patient group

A

Treatment:

Drug: insulin aspart